Show simple item record

The 4F2 heavy chain gene: a molecular model of inducible gene expression in human T cells

dc.contributor.authorLeiden, Jeffrey M.en_US
dc.contributor.authorYang, Li-Huanen_US
dc.contributor.authorMorle, Gerald D.en_US
dc.contributor.authorJune, Carl H.en_US
dc.contributor.authorLindsten, Tulliaen_US
dc.contributor.authorThompson, Craig B.en_US
dc.contributor.authorKarpinski, Beverlyen_US
dc.date.accessioned2006-04-07T20:47:33Z
dc.date.available2006-04-07T20:47:33Z
dc.date.issued1989-06en_US
dc.identifier.citationLeiden, Jeffrey M., Yang, Li-Huan, Morle, Gerald D., June, Carl H., Lindsten, Tullia, Thompson, Craig B., Karpinski, Beverly (1989/06)."The 4F2 heavy chain gene: a molecular model of inducible gene expression in human T cells." Journal of Autoimmunity 2(Supplement 1): 67-79. <http://hdl.handle.net/2027.42/27895>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WHC-4C4NX8Y-M/2/a12db0fd84b5198b181a2718b75aa2b8en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/27895
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2789062&dopt=citationen_US
dc.description.abstractWe have utilized the human 4F2 heavy chain (4F2HC) gene as a model system in studies designed to elucidate the molecular events involved in regulating inducible gene expression during normal human T-cell activation. In previous studies we have shown that steady state levels of 4F2HC mRNA are induced 50-60-fold within 6 h of T-cell activation by phytohemagluttinin (PHA) and that the induction of 4F2HC gene expression involves both the protein kinase C and calcium-mediated activation pathways. Despite the fact that the 4F2HC gene is highly regulated in T cells, the 5' upstream region of the 4F2HC gene contains a housekeeping promoter which is G + C rich, lacks TATA or CCAAT sequences, and contains four potential binding sites for the ubiquitous Sp1 transcription factor. The major regulatory elements of the 4F2HC gene do not reside within this 5' upstream region but instead, map to the exon 1-intron 1 region of the gene. The low levels of mature 4F2HC mRNA in resting T cells result from a block to transcription elongation within the exon 1-intron 1 region of the gene rather than promoter inactivity. Phorbol ester stimulation of resting T cells induces 4F2HC gene expression by removing this block to transcription elongation. We now report that in addition to its ability to serve as a transcriptional attenuator, the 4F2HC first intron contains a powerful enhancer element which is active in a wide variety of cell types including malignant human T cells. Full enhancer activity is displayed by a 186 bp fragment of the first intron which contains binding sites for two novel nuclear proteins (NF-4FA and NF-4FB) which flank a consensus binding site for the AP-1 transcription factor. A cDNA encoding the NF-4FB enhancer binding protein has been cloned by screening a lambda gt11 cDNA library with a rabiolabelled oligonucleotide corresponding to the NF-4FB recognition sequence.en_US
dc.format.extent1981371 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleThe 4F2 heavy chain gene: a molecular model of inducible gene expression in human T cellsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumThe Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; Department of Microbiology/Immunology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; The Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.en_US
dc.identifier.pmid2789062en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/27895/1/0000315.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0896-8411(89)90118-2en_US
dc.identifier.sourceJournal of Autoimmunityen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.